Predictive Factors for Achievement of Treatment Goals in Patients with Postmenopausal Osteoporosis Treated with Denosumab.

Long-term treatment with denosumab was effective in PMO patients. As better baseline T-score predicted achievement of T-scores > -2.5, early initiation of treatment will contribute to better outcome.